HHS unexpectedly canceled a meeting of the U.S. Preventive Services Task Force, prompting fears it may be dismantled following similar moves by Secretary Robert F. Kennedy Jr. at other federal health agencies.
A large real-world study found no significant increase in short-term heart attack or stroke risk among migraine patients using triptans, including those with cardiovascular risk factors.
A large 68-week clinical trial found that a once-weekly combination injection of cagrilintide and semaglutide led to significant and sustained weight loss in adults with overweight or obesity, with over half achieving at least 20% weight reduction.
A study of over 24,000 patients identified four common diagnostic paths that lead to Alzheimer’s disease, with multi-step sequences posing higher risk than single conditions and showing reproducibility in a national validation cohort.
New research using US national survey data found that most adults with high LDL cholesterol are not receiving recommended treatments, and fully following clinical guidelines could prevent hundreds of thousands of cardiovascular events and reduce healthcare costs by billions annually.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A 40-week trial presented at ADA's 85th Scientific Sessions showed that daily oral orforglipron significantly lowered blood sugar and body weight in adults with early type 2 diabetes.
Gut microbiota profiles at 11–13 weeks of pregnancy distinguished women who later developed gestational diabetes mellitus with high diagnostic accuracy.
EASO’s expanded obesity definition incorporating waist-to-height ratio and comorbidities reclassifies 18.8% of overweight adults, but mortality benefits remain uncertain.